Cargando…
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial
Precision medicine programs aim to utilize novel technologies to identify personalized treatments for children with cancer. Delivering these programs requires interdisciplinary efforts, yet the many groups involved are understudied. This study explored the experiences of a broad range of professiona...
Autores principales: | Daly, Rebecca, Hetherington, Kate, Hazell, Emily, Wadling, Bethany R., Tyrrell, Vanessa, Tucker, Katherine M., Marshall, Glenn M., Ziegler, David S., Lau, Loretta M. S., Trahair, Toby N., O’Brien, Tracey A., Collins, Kiri, Gifford, Andrew J., Haber, Michelle, Pinese, Mark, Malkin, David, Cowley, Mark J., Karpelowsky, Jonathan, Drew, Donna, Jacobs, Chris, Wakefield, Claire E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381580/ https://www.ncbi.nlm.nih.gov/pubmed/37511646 http://dx.doi.org/10.3390/jpm13071033 |
Ejemplares similares
-
“Balancing Expectations with Actual Realities”: Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial
por: McGill, Brittany C., et al.
Publicado: (2020) -
DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020) -
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
por: Tsoli, Maria, et al.
Publicado: (2018) -
Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives
por: Wakefield, Claire E., et al.
Publicado: (2023) -
Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer
por: Hetherington, Kate, et al.
Publicado: (2022)